Log in
Enquire now
‌

US Patent 11364224 Pharmaceutical composition for treating migraine

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Upsher-Smith Laboratories
Upsher-Smith Laboratories
Current Assignee
Upsher-Smith Laboratories
Upsher-Smith Laboratories
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11364224
Date of Patent
June 21, 2022
Patent Application Number
16718414
Date Filed
December 18, 2019
Patent Citations
‌
US Patent 10537554 Pharmaceutical composition for treating migraine
Patent Primary Examiner
‌
Craig D Ricci

The present application relates to a method of treating migraine or cluster headache in a human patient, said method comprising administering subcutaneously composition comprising sumatriptan or its pharmaceutically acceptable salt, in an amount equivalent to 3 mg sumatriptan base.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11364224 Pharmaceutical composition for treating migraine

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.